tirzepatide trial obesity without diabetes New drug delivers significant and long-lasting weight loss A 72-week trial compared the
Description
Patients should not take more than prescribed or increase the dose without medical guidance
The main study has been published in The New England Journal of Medicine.
Louisiana is the only exclusion
The day of weekly administration can be changed, if necessary, as long as the time between the 2 doses is at least 3 days (72 hours)
